Article Details

ACADIA Pharmaceuticals (NASDAQ:ACAD) Trading 5.2% Higher Following Analyst Upgrade

Retrieved on: 2021-12-10 07:43:24

Tags for this article:

Click the tags to see associated articles and topics

ACADIA Pharmaceuticals (NASDAQ:ACAD) Trading 5.2% Higher Following Analyst Upgrade. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 10,139,203 shares of the biopharmaceutical company's stock worth $247,295,000 after purchasing an additional 2,737,601 shares ...

Article found on: etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up